METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Clinical trials for METASTATIC TRIPLE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old arthritis drug shows promise against aggressive breast cancer
Disease control CompletedThis study tested leflunomide, a drug usually used for arthritis, in 17 women with metastatic triple negative breast cancer that had already been treated. The goal was to find a safe dose and see if it could stop or shrink tumors. The drug is taken daily by mouth and works by blo…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Joseph Sparano • Aim: Disease control
Last updated May 17, 2026 08:17 UTC
-
New drug combo shows promise for tough breast cancer
Disease control CompletedThis study tested a combination of two drugs, veliparib and lapatinib, in 20 people with metastatic triple negative breast cancer who had already tried other treatments. The goal was to see if the combo was safe and could shrink tumors. Participants received both drugs, not a pla…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 17, 2026 08:00 UTC